Hospitalizations of Nursing Home Residents Can Be Reduced

This article originally appeared here.
Share this content:
Hospitalizations of Nursing Home Residents Can Be Reduced
Hospitalizations of Nursing Home Residents Can Be Reduced

MONDAY, March 20, 2017 (HealthDay News) -- Evidence-based clinical and educational interventions can reduce avoidable hospitalizations among long-stay residents in nursing facilities, according to a report published in the March issue of Health Affairs.

Melvyn J. Ingber, Ph.D., from RTI International in Washington, D.C., and colleagues implemented clinical and educational interventions among long-stay residents in 143 nursing facilities in seven states as part of the Initiative to Reduce Avoidable Hospitalizations among Nursing Facility Residents.

The researchers estimated net reductions of 2.2 to 9.3 percent in the probability of an all-cause hospitalization and 1.4 to 7.2 percent in the probability of a potentially avoidable hospitalization for participating facility residents compared with comparison-group members in 2015 in state-specific analyses. The average Medicare expenditures per resident were reduced by $60 to $2,248 for all-cause hospitalizations and by $98 to $577 for potentially avoidable hospitalizations in 2015. For more than half of the outcomes in these analyses, the effects were significant. The variability in estimated effects was partly explained by variability in implementation and engagement across the nursing facilities and organizations that customized and implemented the initiative. Higher staff engagement and more positive outcomes were seen for initiative models that included registered nurses or nurse practitioners who provided consistent clinical care for residents compared to models providing only education or intermittent clinical care.

"These results provide promising evidence of an effective approach for reducing avoidable hospitalizations among nursing facility residents," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Single-Payer Health System Bill Moves Forward in California

Single-Payer Health System Bill Moves Forward in California

Not yet clear where money for the single-payer system would come from

Regorafenib Approved for Hepatocellular Carcinoma

Regorafenib Approved for Hepatocellular Carcinoma

It is the first approved treatment for HCC in almost a decade

Three Anti-VEGF Treatments Effective for Diabetic Retinopathy

Three Anti-VEGF Treatments Effective for Diabetic Retinopathy

Rates of worsening low in patients receiving aflibercept, bevacizumab, or ranibizumab

is free, fast, and customized just for you!

Already a member?

Sign In Now »